Abstract:Protein Kinase A (PKA) is the major mediator of β-adrenergic (βAR) regulation of cardiac contractility but other mediators (e.g., EPAC) have also been suggested. Reduced PKA basal activity and activation are linked to cardiac diseases. However, the roles of PKA in cardiac physiology and pathology have not been clearly defined because it has been difficult to knockout all expressed PKA catalytic subunit genes in cardiomyocytes. We ablated PKA activity and activation in cardiomyocytes by expressing a PKA inhibitor peptide (PKAi-GFP) in cardiomyocytes in transgenic (TG) mice. We made novel discoveries that: (1) Basal PKA-mediated phosphorylation was reduced for proteins in myofilaments and longitudinal SR but not for proteins in subsarcolemmal and dyadic spaces in PKAi TG hearts, suggesting basal PKA activity is different in individual cellular compartments; (2) PKAi increased the expression of CaMKII, the L-type Ca 2+ channel β subunits and current, but decreased CaMKII phosphorylation; (3) These changes resulted in significantly enhanced myofilament Ca 2+ sensitivity with prolonged contraction and relaxation, decreased myocyte Ca 2+ transient decay rate but enhanced myocyte contractility. (4) PKA inhibition fully abolishes the increases of heart rate, and cardiac and myocyte contractility by a β-adrenergic agonist (isoproterenol, ISO), showing a surprising dominant role of PKA in heart rate regulation and a minimal role of PKA-independent βAR signaling in regulating cardiac function; (5) The increased phosphorylation of proteins mediated by PKA and CaMKII after ISO was prevented by PKAi because increased PKA and CaMKII activation by ISO was eliminated by PKAi in vivo and in vitro . (6) PKAi TG mice maintained partial exercise capability by enhancing basal cardiac function, vascular constriction and ventricular filling (i.e., preload) during βAR stimulation. These features resemble some of the characteristics of diseased hearts. However, PKAi TG mice did not show any cardiac functional or structural abnormalities during the 1-year study period. In conclusion, PKA is the essential mediator of acute βAR regulation of cardiac function and exercise capacity, but the loss of PKA basal activity and activation by βAR agonists do not cause cardiac disease.

A2B adenosine receptor activation and modulation by protein kinase C

A2B adenosine receptor signaling and regulation

Adenosine A1 receptors selectively target protein kinase C isoforms to the caveolin-rich plasma membrane in cardiac myocytes

Inhibition of cAMP-Dependent PKA Activates β2-Adrenergic Receptor Stimulation of Cytosolic Phospholipase A2 via Raf-1/MEK/ERK and IP3-Dependent Ca2+ Signaling in Atrial Myocytes

Early tyrosine phosphorylation events following adenosine A2A receptor in human neutrophils: identification of regulated pathways

β2-Adrenergic Receptor-induced p38 MAPK Activation Is Mediated by Protein Kinase A Rather than by Gi or Gβγ in Adult Mouse Cardiomyocytes

Palmitoylation Regulates Intracellular Trafficking of Β2 Adrenergic Receptor/arrestin/phosphodiesterase 4D Complexes in Cardiomyocytes.

Β-Adrenergic Signaling in the Heart: Dual Coupling of the Β2-Adrenergic Receptor to Gs and Gi Proteins

Recent Advances in Cardiac Β 2 -Adrenergic Signal Transduction

A Long Lasting Β1 Adrenergic Receptor Stimulation of Camp/protein Kinase A (PKA) Signal in Cardiac Myocytes

Recent Advances in Cardiac b2-Adrenergic Signal Transduction

Reconstitution of β-adrenergic regulation of CaV1.2: Rad-dependent and Rad-independent protein kinase A mechanisms

Tripartite interactions of PKA catalytic subunit and C-terminal domains of cardiac Ca2+ channel may modulate its β-adrenergic regulation

FUNCTIONAL COUPLING OF THE BETA(2)-ADRENOCEPTOR TO A PERTUSSIS-TOXIN-SENSITIVE G-PROTEIN IN CARDIAC MYOCYTES

Role of Protein Kinase C in Adenosine A1 Receptor Regulating Opening of Mitochondria Permeability Transition Pore in Hypoxic Cardiac Myocytes

β-blockers augment L-type Ca2+ channel activity by target-selective spatially restricted β2AR-cAMP-PKA signaling in neurons

Ca 2+ participates in α 1B -adrenoceptor-mediated cAMP response in HEK293 cells

Abstract 495: The Loss Of Pka Activity And Activation In Cardiomyocytes Does Not Induce Cardiac Abnormalities

Localized Camp-Dependent Signaling Mediates Beta 2-Adrenergic Modulation of Cardiac Excitation-Contraction Coupling.

A2A R mediated modulation in IP3 levels altering the [Ca2+]i through cAMP-dependent PKA signalling pathway

A3 adenosine receptor activation triggers phosphorylation of protein kinase B and protects rat basophilic leukemia 2H3 mast cells from apoptosis